Allied Market Research
Loading...
0
Allied Market Research

Nanomedicine for Drug Delivery Market by Modality (Diagnostics and Treatments), Product Type (Nanoparticles, Nano-shells, Nanotubes, and Nanodevices), Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), and End User (Hospitals, Specialty Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A12299
Pages: NA
Sep 2021 | 26 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Nanomedicine For Drug Delivery Market

Request Now !

Nanoparticle that is employed in drug delivery is often called nanomedicine. Nano delivery systems and nanomedicines are relatively new but are developing rapidly. In nanomedicine, various materials in the nanoscale range are used to deliver different therapeutic agents to targeted sites in the body in a controlled manner. Nanomedicines are target-oriented, site-specific that help deliver medicines precisely. Different applications of nanomedicine for drug delivery are found these days as they are often used as biological agents, chemotherapeutic agents, and immunotherapeutic agents. In addition, nanomedicines remain in circulation for a prolonged period and also enable the release of drugs at a specific dose. 

Market Scope and Structure Analysis

Report Metric

Details

 Market Size Available for Years

 2020–2030

 Base Year Considered

 2020

 Forecast Period

 2021-2030

 Forecast Unit

 Value (USD)

 Segments Covered

 Modality, Product Type, Indication, End User, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

AbbVie Inc., Aquanova AG, BlueWillow Biologics, Camurus AB, Celgene, Inc., Ceramisphere Health Pty Limited, Cristal Therapeutics, CYTIMMUNE SCIENCES, Inc., EnColl Corporation, EyePoint Pharmaceuticals, Lena Nanoceutics Ltd., Nanobiotix, NanoCarrier Co., Ltd., NanOlogy LLC, and Nanospectra Biosciences, Inc.

 

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in December, 2019. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.

With COVID-19, the supply chain of the raw materials required to manufacture nanomedicine for drug delivery has been disrupted in many countries. In addition, the market growth of nanomedicine for drug delivery is also declining as their manufacturers have slowed down their production because of the pandemic. Therefore, COVID 19 is expected to have a significant impact on the nanomedicine for drug delivery market.

Top Impacting Factors

The surging prevalence of diseases like cancer is likely to propel the growth of nanomedicine for the drug delivery market. Many therapies are currently in pipeline to assist in the treatment of cancer with the use of nanomedicine for proper drug delivery.

The rise in number of people dying from cardiovascular diseases is surging the demand for nanomedicine for drug delivery technology. Hence, this is acting as one of the factors behind the growth of the market.

Demand for novel therapies in treating neurological diseases such as Parkinson's disease, brain tumors, and Alzheimer's disease can further help grow the nanomedicine for drug delivery market.

However, the cost of nanotechnology drug delivery systems for nanosystem is unbearable for people living in developing countries. This factor can impede the growth of nanomedicine for the drug delivery market.

Key Market Trends

FDA- approved therapeutic nanoparticles for various chronic diseases like cancer are currently being developed for reformulating combinations of chemotherapy drugs with polymeric nanoparticles.

North America leads the market of nanomedicine for drug delivery owing to the presence of growing partnerships among major organizations with nanomedicine startup companies. In addition, a number of companies in this region are also focused on developing nanomedicines for cancer treatment.

In Asia-Pacific, nanomedicine for drug delivery market is also expected to expand at a significant rate during the forecast period because of the rise in demand for prophylaxis of chronic diseases and an increased number of research grants by the government.

With increased assistance from the government in funding R&D activities all over the world, the nanomedicine for drug delivery market is expected to find a major share during the forecast period, when it comes to treating neurological disorders such as Parkinson’s disease. 

Key Segments Covered

Segment

Subsegments

 Modality

  • Diagnostics
  • Treatments

 Product Type

  • Nanoparticles
    • Metal And Metal Oxide Nanoparticles
    • Liposomes
    • Polymers & Polymer Drug Conjugates
    • Hydrogel Nanoparticles
    • Dendrimers
    • Inorganic Nanoparticles.
  • Nano-shells
  • Nanotubes
  • Nanodevices

 Indication

  • Oncological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Orthopedic Disorders
  • Neurological Diseases
  • Urological Diseases
  • Ophthalmological Diseases
  • Immunological Diseases and Others

 End User

  • Hospitals
  • Specialty Clinics
  • Others

 Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the nanomedicine for the drug delivery industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the nanomedicine for drug delivery market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the growth scenario of the nanomedicine for drug delivery market.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Nanomedicine for Drug Delivery Report

  • Which are the leading players active in the nanomedicine for drug delivery market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the nanomedicine for drug delivery market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What is nanomedicine for drug delivery?
  • What are the current and predicted trends of the market?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Nanomedicine for Drug Delivery Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers